🔎 Trials Near Me

Почетна › Немалоклетни карцином плућа › Kolorado › Aurora

Kliničke studije za Немалоклетни карцином плућа u gradu Aurora, CO

Jedna studija za Немалоклетни карцином плућа traži učesnike na lokaciji u gradu Aurora ili u blizini. Otvorite je da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

Тражи се учесникФаза 2
  • University of Colorado Cancer Center, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07659782

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Тражи се учесникФаза 3
  • Rocky Mountain Cancer Centers-Aurora, Aurora
  • UCHealth University of Colorado Hospital, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04267848

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Тражи се учесникФаза 1/2
  • UCHealth Cancer Center - Anschutz Medical Campus - University of Colorado Cancer Center, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06914128

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Тражи се учесникФаза 3
  • University of Colorado Anschutz Medical Campus ( Site 0151), Aurora
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT06623422

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

Тражи се учесникФаза 3
  • University of Colorado Cancer Center ( Site 3268), Aurora
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07513376

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1
  • University of Colorado, Aurora
Узраст од 18 до 99 · Оба пола · Ажурирано 6. 11. 2026. · NCT06983743

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Тражи се учесникФаза 3
  • Rocky Mountain Cancer Centers LLP, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07144280

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Тражи се учесникОпсервациона студија
  • Rocky Mountain Cancer Centers-Aurora, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06418204

Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

Тражи се учесникОпсервациона студија
  • University of Colorado Cancer Center at UC Health Sciences Center, Aurora
Узраст од 21 до 90 · Оба пола · Ажурирано 3. 11. 2026. · NCT00900419

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Тражи се учесникФаза 3
  • University of Colorado Health, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07185997

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Тражи се учесникФаза 2/3
  • Local Institution - 007-872-H, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT04613596

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Тражи се учесникФаза 1/2
  • University Of Colorado - Anschutz Medical Campus /ID# 269069, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06772623

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Тражи се учесникФаза 1/2
  • University of Colorado - Aurora Cancer Center, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT05786924

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • Rocky Mountain Regional VA Medical Center, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • UCHealth University of Colorado Hospital, Aurora
18 Minutes · Оба пола · Ажурирано 9. 10. 2026. · NCT06031688

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Тражи се учесникФаза 1/2
  • Rocky Mountain Cancer Centers,LLP, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07227298

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1
  • University of Colorado, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 5. 10. 2026. · NCT06784193

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Тражи се учесникФаза 1/2
  • University of Colorado Cancer Center, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT06128551

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Тражи се учесникФаза 1
  • University of Colorado Cancer Center, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 21. 9. 2026. · NCT05983432

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Тражи се учесникФаза 3
  • Clinical Study Site, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT06767514

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Тражи се учесникОпсервациона студија
  • University of Colorado, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 14. 9. 2026. · NCT05059444

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Тражи се учесникФаза 1
  • University of Colorado Cancer Center, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2026. · NCT06253871

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Тражи се учесникФаза 1
  • University of Colorado Cancer Center, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 3. 9. 2026. · NCT06343402

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Тражи се учесникФаза 1/2
  • University of Colorado Cancer Center, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 26. 8. 2026. · NCT06892548

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

Тражи се учесникФаза 1
  • University of Colorado Hospital - Anschutz Cancer Pavilion (ACP), Aurora
  • University of Colorado Hospital, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 22. 7. 2026. · NCT06131840

Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.

Тражи се учесникОпсервациона студија
  • University of Colorado Hospital, Aurora
Узраст од 18 до 100 · Оба пола · Ажурирано 3. 6. 2026. · NCT03958565

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Тражи се учесникФаза 2
  • UCHealth University of Colorado Hospital, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 3. 6. 2026. · NCT05642572

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Тражи се учесникФаза 1/2
  • University of Colorado Cancer Center, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 13. 4. 2026. · NCT06362369

Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy

Тражи се учесникОпсервациона студија
  • University of Colorado, Cancer Center, Aurora
Узраст од 18 до 85 · Оба пола · Ажурирано 20. 2. 2026. · NCT03042221

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Тражи се учесникОпсервациона студија
  • Massive Bio SYNERGY-AI site, Aurora
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

A Study of NX-1607 in Adults With Advanced Malignancies

Тражи се учесникФаза 1
  • University of Colorado School of Medicine, Aurora
Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2025. · NCT05107674

Studije za Немалоклетни карцином плућа u drugim gradovima

Ostale studije u gradu Aurora

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.